ClassID:

242623

Y10S514/861 - CPC Classification

Classification description:

Recent Application in this class:
#1
20120329835
2012-12-27

USE OF 1-HYDROXY-2- PYRIDONES FOR THE TREATMENT OF SEBORRHEIC DERMATITIS

#2
20120141391
2012-06-07

Use of creatine or creatine compounds for skin preservation

#3
20120087873
2012-04-12

Urea foam

#4
20120045422
2012-02-23

Use of lactic acid bacteria to treat or prevent eczema

#5
20110269801
2011-11-03

Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis

#6
20110112153
2011-05-12

Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis

#7
20110112150
2011-05-12

USE OF 1-HYDROXY-2-PYRIDONES FOR THE TREATMENT OF SEBORRHEIC DERMATITIS

#8
20110091478
2011-04-21

Methods of using antibodies against human IL-22

#9
20110085993
2011-04-14

USE OF CREATINE OR CREATINE COMPOUNDS FOR SKIN PRESERVATION

#10
20110021632
2011-01-27

USE OF CREATINE OR CREATINE COMPOUNDS FOR SKIN PRESERVATION

#11
20110008272
2011-01-13

Use of Creatine or Creatine Compounds for Skin Preservation

#12
20100329997
2010-12-30

USE OF CREATINE OR CREATINE COMPOUNDS FOR SKIN PRESERVATION

#13
20100226870
2010-09-09

USE OF CREATINE OR CREATINE COMPOUNDS FOR SKIN PRESERVATION

#14
20100204320
2010-08-12

PHARMACEUTICALS FOR XEROSIS

#15
20100076031
2010-03-25

USE OF 1-HYDROXY-2-PYRIDONES FOR THE TREATMENT OF SEBORRHEIC DERMATITIS

#16
20100015162
2010-01-21

Methods of using antibodies against human IL-22

#17
20090286871
2009-11-19

Use of a plant oil product as an agent for increasing the synthesis of skin lipids

#18
20090137453
2009-05-28

Composition comprising at least one oxazoline to inhibit migration of langerhans cells, and uses thereof

#19
20090131340
2009-05-21

USE OF FLAVONOIDS AS IMMUNOMODULATING OR IMMUNO-PROTECTIVE AGENTS IN COSMETIC AND DERMATOLOGICAL PREPARATIONS

#20
20090004301
2009-01-01

Method of treating dyshidrosis(pompholyx) and related dry skin disorders

#21
20080175793
2008-07-24

Urea foam

#22
20080170997
2008-07-17

Compositions for the treatment and prevention of cancer

#23
20080032956
2008-02-07

2-ethyl and 2-ethylidene-19-nor-vitamin D compounds

#24
20070258982
2007-11-08

Methods of using antibodies against human IL-22

#25
20070253944
2007-11-01

Use of creatine or creatine compounds for skin preservation

#26
20070155695
2007-07-05

Flavonoid complexes with cyclodextrins

#27
20070088008
2007-04-19

2-ethyl and 2-ethylidene-19-nor-vitamin D compounds

#28
20070059253
2007-03-15

Foamable pharmaceutical compositions and methods for treating a disorder

#29
20060204591
2006-09-14

Treatment of mucosal membranes

#30
20060199784
2006-09-07

Compound selected from sulfated cellulose and salts thereof and dermatitis therapeutic agent

#31
20060104912
2006-05-18

Mousse composition

#32
20060083792
2006-04-20

Therapeutic treatments using the direct application of antimicrobial metal compositions

#33
20050282789
2005-12-22

2-ethyl and 2-ethylidene-19-nor-vitamin D compounds

#34
20050271743
2005-12-08

Treatment of inflammatory skin conditions

#35
20050256084
2005-11-17

Antiallergic composition

#36
20050239724
2005-10-27

Skin penetration enhancing components

#37
20050227996
2005-10-13

Use of creatine or creatine compounds for skin preservation

#38
20050226840
2005-10-13

Use of creatine or creatine compounds for skin preservation

#39
20050192357
2005-09-01

Pharmaceuticals for xerosis

#40
20050186195
2005-08-25

Use of creatine or creatine compounds for skin preservation

#41
20050186194
2005-08-25

Use of creatine or creatine compounds for skin preservation

#42
20050186158
2005-08-25

Use of creatine or creatine compounds for skin preservation

#43
20050106228
2005-05-19

Compositions for the treatment and prevention of cancer

#44
20050089485
2005-04-28

Sulfacetamide formulations for treatment of rosacea

#45
20050084458
2005-04-21

Compositions for the treatment and prevention of cancer

#46
20050075380
2005-04-07

Composition comprising at least one oxazoline for inhibiting langerhans cell migration, and uses thereof

#47
20050043281
2005-02-24

2-Ethyl and 2-ethylidene-19-nor-vitamin D compounds

#48
20050009917
2005-01-13

Antipruritic agent